Short-term mechanical ventilation (MV) is associated with alterations in transcription factor and Id-protein mRNA in rat diaphragm Source: Eur Respir J 2001; 18: Suppl. 33, 420s Year: 2001
Alterations in gene expression in hamster diaphragm after emphysema and lung volume reduction surgery Source: Eur Respir J 2002; 19: 1064-1071 Year: 2002
CRE, but not AP-1, NF-κB, or C/EBP, mediates β-agonist-induced IL-6 gene expression induced in human airway smooth muscle (HASM) cells Source: Eur Respir J 2001; 18: Suppl. 33, 407s Year: 2001
Endothelin receptor B (ETB R) dependent GM-CSF mRNA stabilization explains the higher efficacy of bosentan vs. ambrisentan in the reduction of GM-CSF release from human airway smooth muscle cells (HASMCs) Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
Effect of dexamethasone on TNFα-induced expression of vascular endothelial growth factor (VEGF) in human airway smooth muscle cells - role of histone-acetylation Source: Eur Respir J 2004; 24: Suppl. 48, 695s Year: 2004
Change of mRNA transcription in rat lung pericytes after treatment of LPS or TNF-α Source: Eur Respir J 2006; 28: Suppl. 50, 822s Year: 2006
Effects of rehabilitative exercise on peripheral muscle TNF-α, IL-6, IGF-I, MGF and MyoD expression in COPD Source: Annual Congress 2007 - Effects of training in rehabilitation Year: 2007
The dissociated steroid receptor ligand from plant origin called compound A (CpdA) inhibits the production of steroid-resistant chemokines induced by TNFα/IFNγ in airway smooth muscle (ASM) cells in both asthma and healthy subjects Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012
Erythropoietin (EPO) attenuates the immunohistochemical expression of tumor growth factor-ß (TGF-ß) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018
Inhibitory activity of fluticasone propionate (FP) and salmeterol (SAL) on TGF-β–induced expression of α-smooth muscle actin (α-SMA) by human primary airway fibroblasts (Fbs) Source: Annual Congress 2003 - Cell signalling and cytokines in asthma Year: 2003
Erythropoietin (EPO) attenuates the expression of its receptor (EPO-R) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012
Upregulation of nerve growth factor expression by human airway smooth muscle cells in inflammatory conditions Source: Eur Respir J 2002; 20: 458-463 Year: 2002
Acute impact of percutaneous electrical stimulation (PES) & resistance exercise (RE) on quadriceps muscle gene expression in COPD Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015
Erythropoietin (EPO) attenuates the immunohistochemical expression of autophagy antibodies in bleomycin (BLM), induced pulmonary fibrosis (PF) in rats Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019
Atrophy and hypertrophy signalling in the diaphragm of patients with COPD Source: Eur Respir J 2010; 35: 549-556 Year: 2010
Role of corticosteroids in TNFα-induced expression of vascular endothelial growth factor (VEGF) in human airway smooth muscle cells Source: Annual Congress 2003 - Cell signalling and cytokines in asthma Year: 2003
Role of protein phosphatase 5 (PP5) in mediating corticosteroid insensitivity in airway smooth muscle (ASM) cells in severe asthma Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015
Alterations in myogenic factor and Id-protein mRNA levels in the diaphragm of emphysematous and LVRS-treated hamsters Source: Eur Respir J 2001; 18: Suppl. 33, 421s Year: 2001
Vascular endothelial growth factor (VEGF) mRNA isoforms in an animal model of acute lung injury Source: Annual Congress 2003 - Animal models of lung injury: useful or not? Year: 2003
Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012